JPMorgan Healthcare Lead ETFJDOCETF
13F holders, Q4 2024 (December 31)3holders
2new positions
2sold out
$50.59avg. 13F price*
At the end of Q4 2024, 3 institutions reported holding JPMorgan Healthcare Lead ETF (JDOC) in their 13F filings, unchanged from Q3 2024. 2 opened new positions and 2 sold out. The largest holders were JPMorgan Chase & Co. ($4.5M), Jane Street Group, LLC ($1.1M) and Krilogy Financial LLC ($517K).
- Company
- JPMorgan Healthcare Lead ETF
- CUSIP
- 46654Q765
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $1.7M |
| Exits | 2 | $205K |
All 13F filers, Q3 2024 → Q4 2024: 32,814 shares bought and 3,371 shares sold, net +29,443 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| JPMorgan Chase & Co. | 0.00% | No change | 88,196 | $4.5M |
| Jane Street Group, LLC | 0.00% | New | 22,602 | $1.1M |
| Krilogy Financial LLC | 0.03% | New | 10,212 | $517K |
"% of holder's portfolio" is JDOC's weight in each manager's 13F, not the share of JPMorgan Healthcare Lead ETF the manager owns.